Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Stephan

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Cancers|July 29, 2023
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIVLauren Greenberg, Lene Ryom, Elzbieta Bakowska, et al.
Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
International Journal of Epidemiology|January 2, 2016
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapyLauren E Cain, Michael S Saag, Maya Petersen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries, Dorita Avila, Keri N Althoff, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Cancers|July 29, 2023
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIVLauren Greenberg, Lene Ryom, Elzbieta Bakowska, et al.
Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
International Journal of Epidemiology|January 2, 2016
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapyLauren E Cain, Michael S Saag, Maya Petersen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries, Dorita Avila, Keri N Althoff, et al.
Pageof 15